1. Atezolizumab in combination with carboplatin plus nab-paclitaxel chemotherapy compared with chemotherapy alone as first-line treatment for metastatic non-squamous non-small-cell lung cancer (IMpower130): a multicentre, randomised, open-label, phase 3 trial. Issue 7 (July 2019) Authors: West, Howard; McCleod, Michael; Hussein, Maen; Morabito, Alessandro; Rittmeyer, Achim; Conter, Henry J; Kopp, Hans-Georg; Daniel, Davey; McCune, Steven; Mekhail, Tarek; Zer, Alona; Reinmuth, Niels; Sadiq, Ahad; Sandler, Alan; Lin, Wei; Ochi Lohmann, Tania; Archer, Venice; Wang, Lijia; Kowanetz, M... Journal: Lancet oncology Issue: Volume 20:Issue 7(2019) Page Start: 924 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Impact of prior chemoradiotherapy-related variables on outcomes with durvalumab in unresectable Stage III NSCLC (PACIFIC). (January 2021) Authors: Faivre-Finn, Corinne; Spigel, David R.; Senan, Suresh; Langer, Corey; Perez, Bradford A.; Özgüroğlu, Mustafa; Daniel, Davey; Villegas, Augusto; Vicente, David; Hui, Rina; Murakami, Shuji; Paz-Ares, Luis; Broadhurst, Helen; Wadsworth, Catherine; Dennis, Phillip A.; Antonia, Scott J. Journal: Lung cancer Issue: Volume 151(2021) Page Start: 30 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Patient-reported outcomes with durvalumab after chemoradiotherapy in stage III, unresectable non-small-cell lung cancer (PACIFIC): a randomised, controlled, phase 3 study. Issue 12 (December 2019) Authors: Hui, Rina; Özgüroğlu, Mustafa; Villegas, Augusto; Daniel, Davey; Vicente, David; Murakami, Shuji; Yokoi, Takashi; Chiappori, Alberto; Lee, Ki Hyeong; de Wit, Maike; Cho, Byoung Chul; Gray, Jhanelle E; Rydén, Anna; Viviers, Louis; Poole, Lynne; Zhang, Yiduo; Dennis, Phillip A; Antonia, Scott J Journal: Lancet oncology Issue: Volume 20:Issue 12(2019) Page Start: 1670 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Trilaciclib prior to chemotherapy and atezolizumab in patients with newly diagnosed extensive‐stage small cell lung cancer: A multicentre, randomised, double‐blind, placebo‐controlled Phase II trial. Issue 10 (12th January 2021) Authors: Daniel, Davey; Kuchava, Vladimer; Bondarenko, Igor; Ivashchuk, Oleksandr; Reddy, Sreekanth; Jaal, Jana; Kudaba, Iveta; Hart, Lowell; Matitashvili, Amiran; Pritchett, Yili; Morris, Shannon R.; Sorrentino, Jessica A.; Antal, Joyce M.; Goldschmidt, Jerome Journal: International journal of cancer Issue: Volume 148:Issue 10(2021) Page Start: 2557 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗